封面
市场调查报告书
商品编码
1652584

双极镊子市场成长、规模和趋势分析 - 按类型、应用和最终用户、区域展望和竞争策略进行预测(至 2034 年)

Bipolar Forceps Market Growth, Size, Trends Analysis - By Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 256 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年全球双极钳市场规模将成长至 16,358 亿美元,复合年增长率为 5.45%。

双极钳是电外科手术中用来输送调节电流以止血和/或凝固组织的精密手术器械。双极钳与单极钳不同,它在两点之间输送电流,因此无需接地垫片,并降低了意外组织损伤的风险。这种设计提高了安全性和精确度,特别是在神经外科、眼科和产科等精细手术中。

儘管双极钳在外科手术中的应用越来越广泛,但其行业仍面临许多限制。先进的双极钳价格昂贵,特别是对于微创手术而言,这对资金紧张的医疗机构来说是一个挑战。在新兴国家,对这些工具的认知度较低以及获取途径有限阻碍了市场扩张。

本报告调查了全球双极钳市场,并提供了市场概况摘要、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局以及主要企业的概况。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 驱动因素、限制因素、机会与挑战分析

第五章 市场变数与展望

  • SWOT 分析
  • PESTEL 分析
  • 波特五力分析
  • 热图分析

第六章 竞争格局

  • 製造地、销售区域、产品类型分布
  • 併购、合作伙伴关係、产品发布和合作

7. 全球双极钳市场按类型

  • 一次性的
  • 可重复使用的

8. 全球双极钳市场按应用

  • 妇科
  • 一般外科
  • 神经外科
  • 整形外科
  • 其他的

第 9 章全球双极钳市场(依最终用户)

  • 医院
  • 专科门诊
  • 门诊手术中心

第 10 章 全球双极钳市场

  • 全球双极钳市场规模及市场占有率

第 11 章 全球双极钳市场(按地区)

  • 亚太地区
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • UAE
    • 卡达
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亚
    • 其他的
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美国
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他的

第十二章 公司简介

  • CONMED Corporation
  • Medtronic
  • KLS Martin Group
  • B. Braun SE
  • Stryker
  • BD
  • Johnson & Johnson Services, Inc
  • Integra LifeSciences Corporation
  • Stingray Surgical Products, LLC
  • Surgical Holdings
  • 其他的

第十三章结论

第 14 章简称列表

第 15 章参考链接

简介目录
Product Code: HLCA2522

Bipolar Forceps Market Introduction and Overview

According to SPER market research, 'Bipolar Forceps Market Size- By Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Bipolar Forceps Market is predicted to reach 1635.8 billion by 2034 with a CAGR of 5.45%.

Bipolar forceps are precise surgical tools used in electro surgery that administer a regulated electrical current to stop bleeding or coagulate tissue. Bipolar forceps eliminate the need for a grounding pad and lower the possibility of unintentional tissue damage because they transfer electricity between two points, unlike monopolar tools. Particularly in sensitive operations like neurosurgery, ophthalmology, and obstetrics, this design offers improved safety and accuracy.

Restraints: Notwithstanding its increasing use in surgical operations, the bipolar forceps industry is subject to a number of limitations. Advanced bipolar forceps can be expensive, particularly for minimally invasive procedures, which presents problems for healthcare organizations with limited funding. Market expansion is further hampered in emerging nations by low awareness and limited access to these gadgets.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Type, By Application, By End User.

Regions covere

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

CONMED Corporation; Medtronic; KLS Martin Group; B. Braun SE; Stryker; BD; Johnson & Johnson Services, Inc.; Integra LifeSciences Corporation; Stingray Surgical Products, LLC; Surgical Holdings.

Bipolar Forceps Market Segmentation:

By Type: Based on the Type, Global Bipolar Forceps Market is segmented as; Disposable and Reusable.

By Application: Based on the Application, Global Bipolar Forceps Market is segmented as; Gynaecology, General Surgery, Neurosurgery and Plastic Surgery.

By End User: Based on the End User, Global Bipolar Forceps Market is segmented as; Hospitals, Specialty Clinics and Ambulatory Surgical Centres.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Bipolar Forceps Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bipolar Forceps Market

7. Global Bipolar Forceps Market, By Type (USD Million) 2021-2034

  • 7.1. Disposable
  • 7.2. Reusable

8. Global Bipolar Forceps Market, By Application (USD Million) 2021-2034

  • 8.1. Gynecology
  • 8.2. General Surgery
  • 8.3. Neurosurgery
  • 8.4. Plastic Surgery
  • 8.5. Others

9. Global Bipolar Forceps Market, By End User (USD Million) 2021-2034

  • 9.1. Hospitals
  • 9.2. Specialty Clinics
  • 9.3. Ambulatory Surgical Centers

10. Global Bipolar Forceps Market, (USD Million) 2021-2034

  • 10.1. Global Bipolar Forceps Market Size and Market Share

11. Global Bipolar Forceps Market, By Region, (USD Million) 2021-2034

  • 11.1. Asia-Pacific
    • 11.1.1. Australia
    • 11.1.2. China
    • 11.1.3. India
    • 11.1.4. Japan
    • 11.1.5. South Korea
    • 11.1.6. Rest of Asia-Pacific
  • 11.2. Europe
    • 11.2.1. France
    • 11.2.2. Germany
    • 11.2.3. Italy
    • 11.2.4. Spain
    • 11.2.5. United Kingdom
    • 11.2.6. Rest of Europe
  • 11.3. Middle East and Africa
    • 11.3.1. Kingdom of Saudi Arabia
    • 11.3.2. United Arab Emirates
    • 11.3.3. Qatar
    • 11.3.4. South Africa
    • 11.3.5. Egypt
    • 11.3.6. Morocco
    • 11.3.7. Nigeria
    • 11.3.8. Rest of Middle-East and Africa
  • 11.4. North America
    • 11.4.1. Canada
    • 11.4.2. Mexico
    • 11.4.3. United States
  • 11.5. Latin America
    • 11.5.1. Argentina
    • 11.5.2. Brazil
    • 11.5.3. Rest of Latin America

12. Company Profile

  • 12.1. CONMED Corporation
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Medtronic
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. KLS Martin Group
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. B. Braun SE
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Stryker
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. BD
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Johnson & Johnson Services, Inc
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Integra LifeSciences Corporation
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Stingray Surgical Products, LLC
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Surgical Holdings
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. Others

13. Conclusion

14. List of Abbreviations

15. Reference Links